Search

Search Constraints

You searched for: Author/Creator Cavalloni, Chiara

Search Results

3. Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group. Issue 1 (1st November 2019)

4. Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib. Issue 4 (22nd July 2020)

5. Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia. (June 2018)

7. Prognostic impact of somatic mutations on time to first treatment: Results of targeted next‐generation sequencing in 211 patients with early stage chronic lymphocytic leukemia. Issue 11 (11th August 2021)

8. Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms. Issue 7 (1st May 2019)

9. Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. (15th February 2023)

10. Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting. Issue 13 (10th November 2021)